{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T11:53:05Z","timestamp":1794743585441,"version":"4.9.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Multiple myeloma (MM) is a highly heterogeneous disease of malignant plasma cells. Diagnosis and monitoring of MM patients is based on bone marrow biopsies and detection of abnormal immunoglobulin in serum and\/or urine. However, biopsies have a single-site bias; thus, new diagnostic tests and early detection strategies are needed. Matrix-Assisted Laser Desorption\/Ionization Time-of Flight Mass Spectrometry (MALDI-TOF MS) is a powerful method that found its applications in clinical diagnostics. Artificial intelligence approaches, such as Artificial Neural Networks (ANNs), can handle non-linear data and provide prediction and classification of variables in multidimensional datasets. In this study, we used MALDI-TOF MS to acquire low mass profiles of peripheral blood plasma obtained from MM patients and healthy donors. Informative patterns in mass spectra served as inputs for ANN that specifically predicted MM samples with high sensitivity (100%), specificity (95%) and accuracy (98%). Thus, mass spectrometry coupled with ANN can provide a minimally invasive approach for MM diagnostics.<\/jats:p>","DOI":"10.1038\/s41598-019-44215-1","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:04:40Z","timestamp":1559037880000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Rapid discrimination of multiple myeloma patients by artificial neural networks coupled with mass spectrometry of peripheral blood plasma"],"prefix":"10.1038","volume":"9","author":[{"given":"Meritxell","family":"Deulofeu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Kol\u00e1\u0159ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Salvad\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1474-3134","authenticated-orcid":false,"given":"Eladia","family":"Mar\u00eda Pe\u00f1a-M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Alm\u00e1\u0161i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"\u0160tork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lud\u011bk","family":"Pour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8497-1207","authenticated-orcid":false,"given":"Pere","family":"Boadas-Vaello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7194-6771","authenticated-orcid":false,"given":"Sabina","family":"\u0160ev\u010d\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Havel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Va\u0148hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,28]]},"reference":[{"key":"44215_CR1","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/clinchem\/46.8.1230","volume":"46","author":"M Attaelmannan","year":"2000","unstructured":"Attaelmannan, M. & Levinson, S. S. Understanding and identifying monoclonal gammopathies. Clin. Chem. 46, 1230\u20131238 (2000).","journal-title":"Clin. Chem."},{"key":"44215_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/leu.2008.291","volume":"23","author":"RA Kyle","year":"2009","unstructured":"Kyle, R. A. & Rajkumar, S. V. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 23, 3\u20139 (2009).","journal-title":"Leukemia"},{"key":"44215_CR3","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar, S. V. et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 15, e538\u2013548 (2014).","journal-title":"Lancet Oncol."},{"key":"44215_CR4","doi-asserted-by":"publisher","first-page":"vii143","DOI":"10.1093\/annonc\/mdq370","volume":"21","author":"MA Dimopoulos","year":"2010","unstructured":"Dimopoulos, M. A. & Terpos, E. Multiple myeloma. Ann. Oncol. 21, vii143\u2013150 (2010).","journal-title":"Ann. Oncol."},{"key":"44215_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.14735\/amko20172S35","volume":"30","author":"D Maluskova","year":"2017","unstructured":"Maluskova, D. et al. Epidemiology of Multiple Myeloma in the Czech Republic. Klin.Onkol. 30, 35\u201342 (2017).","journal-title":"Klin.Onkol."},{"key":"44215_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/1471-2407-12-415","volume":"12","author":"R Hajek","year":"2012","unstructured":"Hajek, R., Bryce, R., Ro, S., Klencke, B. & Ludwig, H. Design and rationale of FOCUS (PX-171-011): a randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R\/R MM). BMC Cancer 12, 415\u2013422 (2012).","journal-title":"BMC Cancer"},{"key":"44215_CR7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1182\/blood-2018-10-875138","volume":"132","author":"BA Walker","year":"2018","unstructured":"Walker, B. A. et al. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma. Blood 132, 587\u2013597 (2018).","journal-title":"Blood"},{"key":"44215_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.14735\/amko20172S13","volume":"30","author":"V Kubaczkova","year":"2017","unstructured":"Kubaczkova, V. et al. Liquid Biopsies - the Clinics and the Molecules. Klin. Onkol. 30, 13\u20132 (2017).","journal-title":"Klin. Onkol."},{"key":"44215_CR9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/labinvest.3700097","volume":"84","author":"J Tolson","year":"2004","unstructured":"Tolson, J. et al. Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients. Lab. Invest. 84, 845\u2013856 (2004).","journal-title":"Lab. Invest."},{"key":"44215_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1309\/LMXWEJV3FFDR0DHH","volume":"42","author":"H Jin","year":"2011","unstructured":"Jin, H. et al. Discrimination Analysis of Mass Spectrometry Proteomics for Lung Adenocarcinoma Detection. Lab Medicine 42, 344\u2013349 (2011).","journal-title":"Lab Medicine"},{"key":"44215_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/pmic.200300399","volume":"3","author":"LF Steel","year":"2003","unstructured":"Steel, L. F. et al. A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma. Proteomics 3, 601\u2013609 (2003).","journal-title":"Proteomics"},{"key":"44215_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1479-5876-7-60","volume":"7","author":"M Pietrowska","year":"2009","unstructured":"Pietrowska, M. et al. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer. J. Transl. Med. 7, 60\u201373 (2009).","journal-title":"J. Transl. Med."},{"key":"44215_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1479-5876-8-66","volume":"8","author":"M Pietrowska","year":"2010","unstructured":"Pietrowska, M. et al. Mass spectrometry-based analysis of therapy-related changes in serum proteome patterns of patients with early-stage breast cancer. J. Transl. Med. 8, 66\u201377 (2010).","journal-title":"J. Transl. Med."},{"key":"44215_CR14","doi-asserted-by":"publisher","first-page":"6550","DOI":"10.1158\/1078-0432.CCR-05-0983","volume":"11","author":"M Roessler","year":"2005","unstructured":"Roessler, M. et al. Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer. Clin. Cancer. Res. 11, 6550\u20136557 (2005).","journal-title":"Clin. Cancer. Res."},{"key":"44215_CR15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.urolonc.2004.04.008","volume":"22","author":"WE Grizzle","year":"2004","unstructured":"Grizzle, W. E. et al. The Early Detection Research Network surface-enhanced laser desorption and ionization prostate cancer detection study: a study in biomarker validation in genitourinary oncology. Urol. Oncol. 22, 337\u2013343 (2004).","journal-title":"Urol. Oncol."},{"key":"44215_CR16","doi-asserted-by":"publisher","first-page":"12343","DOI":"10.1073\/pnas.2033602100","volume":"100","author":"KR Kozak","year":"2003","unstructured":"Kozak, K. R. et al. Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis. Proc. Natl. Acad. Sci. USA 100, 12343\u201312348 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"44215_CR17","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s12185-012-1080-3","volume":"95","author":"AL He","year":"2012","unstructured":"He, A. L. et al. Detection of serum tumor markers in multiple myeloma using the CLINPROT system. Int. J. Hematol. 95, 668\u2013674 (2012).","journal-title":"Int. J. Hematol."},{"key":"44215_CR18","doi-asserted-by":"publisher","first-page":"4770","DOI":"10.1158\/1078-0432.CCR-12-2917","volume":"19","author":"L Puchades-Carrasco","year":"2013","unstructured":"Puchades-Carrasco, L. et al. Multiple myeloma patients have a specific serum metabolomic profile that changes after achieving complete remission. Clin. Cancer Res. 19, 4770\u20134779 (2013).","journal-title":"Clin. Cancer Res."},{"key":"44215_CR19","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/ar.20871","volume":"292","author":"QT Wang","year":"2009","unstructured":"Wang, Q. T. et al. Construction of A Multiple Myeloma Diagnostic Model by Magnetic Bead-Based MALDI-TOF Mass Spectrometry of Serum and Pattern Recognition Software. Anat. Rec. 292, 604\u2013610 (2009).","journal-title":"Anat. Rec."},{"key":"44215_CR20","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.4103\/0366-6999.155112","volume":"128","author":"HT Zhang","year":"2015","unstructured":"Zhang, H. T., Tian, E. B., Chen, Y. L., Deng, H. T. & Wang, Q. T. Proteomic Analysis for Finding Serum Pathogenic Factors and Potential Biomarkers in Multiple Myeloma. Chin. Med. J. 128, 1108\u20131113 (2015).","journal-title":"Chin. Med. J."},{"key":"44215_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1155\/2006\/728296","volume":"22","author":"S Bhattacharyya","year":"2006","unstructured":"Bhattacharyya, S., Epstein, J. & Suva, L. J. Biomarkers that discriminate multiple myeloma patients with or without skeletal involvement detected using SELDI-TOF mass spectrometry and statistical and machine learning tools. Dis. Markers 22, 245\u2013255 (2006).","journal-title":"Dis. Markers"},{"key":"44215_CR22","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1186\/1471-2164-15-904","volume":"15","author":"P Dowling","year":"2014","unstructured":"Dowling, P. et al. Identification of proteins found to be significantly altered when comparing the serum proteome from Multiple Myeloma patients with varying degrees of bone disease. BMC Genomics 15, 904\u2013916 (2014).","journal-title":"BMC Genomics"},{"key":"44215_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0167-7012(00)00201-3","volume":"43","author":"IA Basheer","year":"2000","unstructured":"Basheer, I. A. & Hajmeer, M. Artificial neural networks: fundamentals, computing, design, and application. J. Microbiol. Methods 43, 3\u201331 (2000).","journal-title":"J. Microbiol. Methods"},{"key":"44215_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2478\/v10136-012-0031-x","volume":"11","author":"F Amato","year":"2013","unstructured":"Amato, F. et al. Artificial neural networks in medical diagnosis. J. Appl. Biomed. 11, 47\u201358 (2013).","journal-title":"J. Appl. Biomed."},{"key":"44215_CR25","doi-asserted-by":"publisher","first-page":"e0147414","DOI":"10.1371\/journal.pone.0147414","volume":"11","author":"E Valletta","year":"2016","unstructured":"Valletta, E. et al. Multivariate Calibration Approach for Quantitative Determination of Cell-Line Cross Contamination by Intact Cell Mass Spectrometry and Artificial Neural Networks. PLoS ONE 11, e0147414 (2016).","journal-title":"PLoS ONE"},{"key":"44215_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jab.2013.12.001","volume":"12","author":"J Houska","year":"2014","unstructured":"Houska, J. et al. Tissue profiling by nanogold-mediated mass spectrometry and artificial neural networks in the mouse model of human primary hyperoxaluria 1. J. Appl. Biomed. 12, 119\u2013125 (2014).","journal-title":"J. Appl. Biomed."},{"key":"44215_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/sctm.17-0107","volume":"7","author":"P Vanhara","year":"2018","unstructured":"Vanhara, P. et al. Intact Cell Mass Spectrometry as a Quality Control Tool for Revealing Minute Phenotypic Changes of Cultured Human Embryonic Stem Cells. Stem Cells Transl. Med. 7, 109\u2013114 (2018).","journal-title":"Stem Cells Transl. Med."},{"key":"44215_CR28","first-page":"44","volume":"19","author":"CAD Medriano","year":"2017","unstructured":"Medriano, C. A. D., Na, J., Lim, K. M., Chung, J. H. & Park, Y. H. Liquid Chromatography Mass Spectrometry-Based Metabolite Pathway Analyses of Myeloma and Non-Hodgkin\u2019s Lymphoma Patients. Cell J. 19, 44\u201354 (2017).","journal-title":"Cell J."},{"key":"44215_CR29","doi-asserted-by":"publisher","first-page":"e0202045","DOI":"10.1371\/journal.pone.0202045","volume":"13","author":"N Steiner","year":"2018","unstructured":"Steiner, N. et al. The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets. PLoS ONE 13, e0202045 (2018).","journal-title":"PLoS ONE"},{"key":"44215_CR30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s13361-016-1567-x","volume":"28","author":"L Kolarova","year":"2017","unstructured":"Kolarova, L. et al. Clusters of Monoisotopic Elements for Calibration in (TOF) Mass Spectrometry. J. Am. Soc. Mass. Spectrom. 28, 419\u2013427 (2017).","journal-title":"J. Am. Soc. Mass. Spectrom."},{"key":"44215_CR31","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1093\/bioinformatics\/bts447","volume":"28","author":"S Gibb","year":"2012","unstructured":"Gibb, S. & Strimmer, K. MALDIquant: a versatile R package for the analysis of mass spectrometry data. Bioinformatics 28, 2270\u20132271 (2012).","journal-title":"Bioinformatics"},{"key":"44215_CR32","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00521-013-1408-9","volume":"23","author":"D Baptista","year":"2013","unstructured":"Baptista, D. & Morgado-Dias, F. A survey of artificial neural network training tools. Neural Comput. Appl. 23, 609\u2013615 (2013).","journal-title":"Neural Comput. Appl."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44215-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44215-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44215-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T09:59:30Z","timestamp":1671271170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-44215-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["44215"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-44215-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,28]]},"assertion":[{"value":"21 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7975"}}